Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06502067

Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery

Efficacy of Serratus Posterior Superior Intercostal Plane Block (SPSIPB) on Perioperative Analgesia and Inflamatory Markers in Breast Surgery

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To study the efficiacy of serratus posterior superior block in controlling perioperative breast cancer surgery pain and its effect on inflamatory markers.

Detailed description

Back ground The presence of pain during the initial course of treatment in women with early-stage breast cancer was associated with significantly higher levels of c-reactive protein(CRP) ,interleukin-7(IL-7)and interleukin-13(IL-13) There is evidence of effectiveness of regional block in controlling inflamatory markers Serratus posterior superior intercostal plane block (SPSIPB) is a novel Regional technique that provides analgesia in the hemithorax, shoulder, and back of the neck which proved its efficacy in controlling pain after Video assisted thoracoscopic surgery there are little epidemiological data on (SPSIPB)usage in masectomy and lumpectomy procedures and its effect on inflamatory markers Methodology: * Type of the Study: Randomized prospective comparative controlled double-blinded study * Study Setting: Ain Shams University Hospitals * Study Period: One year after approval of the protocol. * Place :Ain shams university hospitals * Study Population: Adult patients who will undergo breast cancer surgey.

Conditions

Interventions

TypeNameDescription
DRUGAnalgesia mangement group A,B1gm of paracetamol, 30mg of ketorolac and 1mg Granitryl will be given twenty minutes before the end of the operation .

Timeline

Start date
2024-07-25
Primary completion
2025-06-02
Completion
2025-07-01
First posted
2024-07-15
Last updated
2024-07-23

Source: ClinicalTrials.gov record NCT06502067. Inclusion in this directory is not an endorsement.